| 0 |
GASTRIC FIBROSIS |
4 |
0.2353 |
| 1 |
URINARY SQUAMOUS EPITHELIAL CELLS INCREASED |
1 |
0.1250 |
| 2 |
CROWNED DENS SYNDROME |
1 |
0.0323 |
| 3 |
INFUSION SITE EXFOLIATION |
1 |
0.0192 |
| 4 |
TESTICULAR INFARCTION |
1 |
0.0167 |
| 5 |
VAGINAL NEOPLASM |
1 |
0.0110 |
| 6 |
BACTERIAL VULVOVAGINITIS |
3 |
0.0104 |
| 7 |
COLORECTAL ADENOMA |
3 |
0.0093 |
| 8 |
ENDOSCOPY ABNORMAL |
1 |
0.0075 |
| 9 |
CARCINOMA IN SITU |
1 |
0.0060 |
| 10 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
4 |
0.0052 |
| 11 |
FAMILIAL MEDITERRANEAN FEVER |
1 |
0.0051 |
| 12 |
GASTROENTERITIS SALMONELLA |
4 |
0.0048 |
| 13 |
STOMA OBSTRUCTION |
1 |
0.0044 |
| 14 |
URINARY OCCULT BLOOD POSITIVE |
1 |
0.0043 |
| 15 |
HERPES ZOSTER CUTANEOUS DISSEMINATED |
1 |
0.0043 |
| 16 |
AMOEBIASIS |
1 |
0.0043 |
| 17 |
TUBERCULOUS PLEURISY |
2 |
0.0042 |
| 18 |
PERIPHERAL VEIN THROMBOSIS |
1 |
0.0042 |
| 19 |
PANCREATIC CARCINOMA RECURRENT |
1 |
0.0041 |
| 20 |
INTESTINAL SEPSIS |
1 |
0.0038 |
| 21 |
LISTERIA SEPSIS |
1 |
0.0038 |
| 22 |
FAECAL CALPROTECTIN INCREASED |
11 |
0.0035 |
| 23 |
COLITIS ULCERATIVE |
155 |
0.0035 |
| 24 |
RELAPSING FEVER |
1 |
0.0035 |
| 25 |
ANAL SQUAMOUS CELL CARCINOMA |
1 |
0.0032 |
| 26 |
INCREASED DOSE ADMINISTERED |
1 |
0.0032 |
| 27 |
HEPATIC VEIN THROMBOSIS |
1 |
0.0032 |
| 28 |
CEREBRAL AMYLOID ANGIOPATHY |
1 |
0.0030 |
| 29 |
GIARDIASIS |
1 |
0.0029 |
| 30 |
DIVERTICULITIS INTESTINAL PERFORATED |
1 |
0.0028 |
| 31 |
BODY TINEA |
1 |
0.0018 |
| 32 |
POSTOPERATIVE ILEUS |
1 |
0.0018 |
| 33 |
CELLULITIS ORBITAL |
1 |
0.0017 |
| 34 |
INFUSION RELATED HYPERSENSITIVITY REACTION |
1 |
0.0017 |
| 35 |
MEAN PLATELET VOLUME INCREASED |
1 |
0.0017 |
| 36 |
RECTAL ADENOCARCINOMA |
1 |
0.0017 |
| 37 |
INFUSION SITE URTICARIA |
1 |
0.0015 |
| 38 |
HEAD AND NECK CANCER |
1 |
0.0015 |
| 39 |
PNEUMOTHORAX SPONTANEOUS |
1 |
0.0015 |
| 40 |
CUTANEOUS SYMPTOM |
1 |
0.0015 |
| 41 |
ARACHNOIDITIS |
1 |
0.0014 |
| 42 |
MANTLE CELL LYMPHOMA |
2 |
0.0013 |
| 43 |
EXTRADURAL ABSCESS |
1 |
0.0013 |
| 44 |
PRODUCT INEFFECTIVE |
1 |
0.0013 |
| 45 |
ENDOCARDITIS BACTERIAL |
1 |
0.0013 |
| 46 |
HERPES ZOSTER DISSEMINATED |
1 |
0.0012 |
| 47 |
ANAL ULCER |
1 |
0.0012 |
| 48 |
IGA NEPHROPATHY |
2 |
0.0012 |
| 49 |
CEREBRAL VENOUS SINUS THROMBOSIS |
1 |
0.0012 |
| 50 |
ENZYME LEVEL INCREASED |
1 |
0.0012 |
| 51 |
DISSEMINATED TUBERCULOSIS |
3 |
0.0012 |
| 52 |
LUNG HYPERINFLATION |
1 |
0.0012 |
| 53 |
POUCHITIS |
1 |
0.0012 |
| 54 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
1 |
0.0011 |
| 55 |
LARGE INTESTINAL ULCER |
3 |
0.0011 |
| 56 |
RECTAL CANCER |
3 |
0.0010 |
| 57 |
CHOLANGITIS SCLEROSING |
2 |
0.0010 |
| 58 |
INFUSION SITE DISCOMFORT |
1 |
0.0010 |
| 59 |
INJECTION SITE HYPERSENSITIVITY |
3 |
0.0010 |
| 60 |
SMALL INTESTINAL STENOSIS |
1 |
0.0009 |
| 61 |
FREQUENT BOWEL MOVEMENTS |
25 |
0.0009 |
| 62 |
CLOSTRIDIUM TEST POSITIVE |
2 |
0.0009 |
| 63 |
CLOSTRIDIAL INFECTION |
3 |
0.0009 |
| 64 |
HYPERSENSITIVITY PNEUMONITIS |
1 |
0.0009 |
| 65 |
PRURITUS ALLERGIC |
1 |
0.0009 |
| 66 |
GROIN ABSCESS |
1 |
0.0008 |
| 67 |
UPPER RESPIRATORY TRACT INFLAMMATION |
1 |
0.0008 |
| 68 |
PYODERMA GANGRENOSUM |
3 |
0.0008 |
| 69 |
PREMATURE RUPTURE OF MEMBRANES |
2 |
0.0008 |
| 70 |
BREECH PRESENTATION |
1 |
0.0008 |
| 71 |
NECROTISING COLITIS |
1 |
0.0008 |
| 72 |
VULVOVAGINAL MYCOTIC INFECTION |
3 |
0.0008 |
| 73 |
HYPOVITAMINOSIS |
1 |
0.0008 |
| 74 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
3 |
0.0007 |
| 75 |
INTESTINAL MASS |
1 |
0.0007 |
| 76 |
DEATH NEONATAL |
1 |
0.0007 |
| 77 |
INTESTINAL FISTULA |
1 |
0.0007 |
| 78 |
MYELITIS TRANSVERSE |
1 |
0.0007 |
| 79 |
PNEUMONIA PSEUDOMONAL |
1 |
0.0007 |
| 80 |
MYELITIS |
1 |
0.0006 |
| 81 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
1 |
0.0006 |
| 82 |
MEGACOLON |
1 |
0.0006 |
| 83 |
HAEMATOCHEZIA |
35 |
0.0006 |
| 84 |
INFUSION SITE PRURITUS |
2 |
0.0006 |
| 85 |
HEPATITIS E |
1 |
0.0006 |
| 86 |
LOSS OF THERAPEUTIC RESPONSE |
2 |
0.0006 |
| 87 |
INFLAMMATORY BOWEL DISEASE |
6 |
0.0006 |
| 88 |
PAPILLOMA VIRAL INFECTION |
1 |
0.0006 |
| 89 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 90 |
ACUTE SINUSITIS |
1 |
0.0006 |
| 91 |
SERUM FERRITIN DECREASED |
1 |
0.0006 |
| 92 |
DEFAECATION URGENCY |
4 |
0.0006 |
| 93 |
GASTROINTESTINAL OEDEMA |
1 |
0.0006 |
| 94 |
BREAST CYST |
1 |
0.0006 |
| 95 |
OPHTHALMIC HERPES ZOSTER |
1 |
0.0006 |
| 96 |
INTESTINAL ISCHAEMIA |
3 |
0.0005 |
| 97 |
SENSITIVE SKIN |
4 |
0.0005 |
| 98 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 99 |
DIARRHOEA HAEMORRHAGIC |
5 |
0.0005 |
| 100 |
ADENOCARCINOMA OF COLON |
1 |
0.0005 |
| 101 |
SMALL INTESTINAL PERFORATION |
1 |
0.0005 |
| 102 |
STENOSIS |
1 |
0.0005 |
| 103 |
WHITE BLOOD CELLS URINE POSITIVE |
1 |
0.0005 |
| 104 |
SACROILIITIS |
1 |
0.0005 |
| 105 |
CONVERSION DISORDER |
1 |
0.0005 |
| 106 |
EARLY SATIETY |
1 |
0.0005 |
| 107 |
HYPERAEMIA |
1 |
0.0005 |
| 108 |
LARGE INTESTINAL STENOSIS |
1 |
0.0005 |
| 109 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
5 |
0.0005 |
| 110 |
DIVERTICULAR PERFORATION |
1 |
0.0005 |
| 111 |
VENOUS THROMBOSIS LIMB |
1 |
0.0005 |
| 112 |
VARICELLA ZOSTER VIRUS INFECTION |
1 |
0.0005 |
| 113 |
INJECTION SITE DISCOMFORT |
5 |
0.0005 |
| 114 |
EAR SWELLING |
1 |
0.0005 |
| 115 |
INFUSION SITE BRUISING |
1 |
0.0005 |
| 116 |
MONOPLEGIA |
2 |
0.0005 |
| 117 |
OLIGOMENORRHOEA |
1 |
0.0005 |
| 118 |
HENOCH-SCHONLEIN PURPURA |
1 |
0.0005 |
| 119 |
BACTERIAL TEST POSITIVE |
1 |
0.0004 |
| 120 |
PULMONARY TOXICITY |
3 |
0.0004 |
| 121 |
PRE-ECLAMPSIA |
2 |
0.0004 |
| 122 |
PULSE ABNORMAL |
1 |
0.0004 |
| 123 |
INFLAMMATORY MARKER INCREASED |
2 |
0.0004 |
| 124 |
APPENDICITIS PERFORATED |
1 |
0.0004 |
| 125 |
NOCARDIOSIS |
1 |
0.0004 |
| 126 |
FEMORAL NECK FRACTURE |
2 |
0.0004 |
| 127 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 128 |
HEPATITIS TOXIC |
1 |
0.0004 |
| 129 |
WHITE BLOOD CELL DISORDER |
1 |
0.0004 |
| 130 |
COMPRESSION FRACTURE |
2 |
0.0004 |
| 131 |
ANAL ABSCESS |
2 |
0.0004 |
| 132 |
CLUMSINESS |
1 |
0.0004 |
| 133 |
INTRACRANIAL PRESSURE INCREASED |
2 |
0.0004 |
| 134 |
THERAPEUTIC RESPONSE DELAYED |
1 |
0.0004 |
| 135 |
PYELONEPHRITIS |
3 |
0.0003 |
| 136 |
SPINAL OSTEOARTHRITIS |
3 |
0.0003 |
| 137 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 138 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 139 |
SYMPTOM RECURRENCE |
2 |
0.0003 |
| 140 |
FOETAL GROWTH RESTRICTION |
2 |
0.0003 |
| 141 |
ISCHAEMIC CARDIOMYOPATHY |
1 |
0.0003 |
| 142 |
FIBROSIS |
1 |
0.0003 |
| 143 |
ILEUS |
4 |
0.0003 |
| 144 |
INFUSION SITE SWELLING |
2 |
0.0003 |
| 145 |
BILE DUCT STONE |
1 |
0.0003 |
| 146 |
PORTAL VEIN THROMBOSIS |
1 |
0.0003 |
| 147 |
THROMBOSIS IN DEVICE |
1 |
0.0003 |
| 148 |
NEPHROTIC SYNDROME |
2 |
0.0003 |
| 149 |
INJECTION SITE PAIN |
89 |
0.0003 |
| 150 |
LARGE INTESTINE PERFORATION |
2 |
0.0003 |
| 151 |
CAROTID ARTERY STENOSIS |
1 |
0.0003 |
| 152 |
SPONDYLITIS |
1 |
0.0003 |
| 153 |
CUTANEOUS VASCULITIS |
1 |
0.0003 |
| 154 |
IMMUNE-MEDIATED ENTEROCOLITIS |
1 |
0.0003 |
| 155 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
2 |
0.0003 |
| 156 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0003 |
| 157 |
MATERNAL EXPOSURE DURING PREGNANCY |
23 |
0.0003 |
| 158 |
APHTHOUS ULCER |
2 |
0.0003 |
| 159 |
FAECES HARD |
1 |
0.0003 |
| 160 |
HAEMORRHOIDS |
5 |
0.0003 |
| 161 |
PROCEDURAL HAEMORRHAGE |
1 |
0.0003 |
| 162 |
BLOOD IRON DECREASED |
3 |
0.0003 |
| 163 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 164 |
OBSTRUCTION |
1 |
0.0003 |
| 165 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 166 |
CEREBRAL INFARCTION |
6 |
0.0002 |
| 167 |
DEMYELINATION |
1 |
0.0002 |
| 168 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 169 |
AORTIC DISSECTION |
1 |
0.0002 |
| 170 |
CYTOMEGALOVIRUS INFECTION |
4 |
0.0002 |
| 171 |
INTESTINAL STENOSIS |
1 |
0.0002 |
| 172 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 173 |
LUNG NEOPLASM |
1 |
0.0002 |
| 174 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1 |
0.0002 |
| 175 |
PAPILLOEDEMA |
1 |
0.0002 |
| 176 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 177 |
APPENDICITIS |
2 |
0.0002 |
| 178 |
ACCIDENTAL UNDERDOSE |
3 |
0.0002 |
| 179 |
FIBROMYALGIA |
5 |
0.0002 |
| 180 |
HORMONE LEVEL ABNORMAL |
1 |
0.0002 |
| 181 |
HAEMORRHOIDAL HAEMORRHAGE |
1 |
0.0002 |
| 182 |
RENAL CELL CARCINOMA |
1 |
0.0002 |
| 183 |
MUCOUS STOOLS |
1 |
0.0002 |
| 184 |
COLON CANCER |
3 |
0.0002 |
| 185 |
ANEURYSM |
1 |
0.0002 |
| 186 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 187 |
ABORTION SPONTANEOUS |
8 |
0.0002 |
| 188 |
ERYSIPELAS |
1 |
0.0002 |
| 189 |
TONSILLITIS |
1 |
0.0002 |
| 190 |
ANAL FISTULA |
1 |
0.0002 |
| 191 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 192 |
INTERSTITIAL LUNG DISEASE |
9 |
0.0002 |
| 193 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 194 |
HYDROCEPHALUS |
1 |
0.0002 |
| 195 |
CLOSTRIDIUM DIFFICILE INFECTION |
4 |
0.0002 |
| 196 |
MELAENA |
4 |
0.0002 |
| 197 |
DEAFNESS UNILATERAL |
1 |
0.0002 |
| 198 |
CHOKING SENSATION |
1 |
0.0002 |
| 199 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
2 |
0.0002 |
| 200 |
INTERMENSTRUAL BLEEDING |
1 |
0.0002 |
| 201 |
INTESTINAL PERFORATION |
2 |
0.0002 |
| 202 |
FISTULA |
2 |
0.0002 |
| 203 |
PREMATURE LABOUR |
1 |
0.0002 |
| 204 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 205 |
PERONEAL NERVE PALSY |
1 |
0.0002 |
| 206 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 207 |
ENTEROCOLITIS |
1 |
0.0002 |
| 208 |
POST PROCEDURAL HAEMORRHAGE |
2 |
0.0002 |
| 209 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 210 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 211 |
C-REACTIVE PROTEIN INCREASED |
6 |
0.0002 |
| 212 |
RECTAL HAEMORRHAGE |
7 |
0.0002 |
| 213 |
INJECTION SITE MASS |
6 |
0.0002 |
| 214 |
CHOLANGITIS |
1 |
0.0002 |
| 215 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 216 |
EPSTEIN-BARR VIRUS INFECTION |
1 |
0.0002 |
| 217 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 218 |
INJECTION SITE INDURATION |
2 |
0.0002 |
| 219 |
HYPERPROLACTINAEMIA |
1 |
0.0002 |
| 220 |
DRUG SPECIFIC ANTIBODY PRESENT |
1 |
0.0002 |
| 221 |
ORAL HERPES |
3 |
0.0002 |
| 222 |
SKIN MASS |
1 |
0.0001 |
| 223 |
MENINGITIS |
1 |
0.0001 |
| 224 |
THERAPEUTIC RESPONSE DECREASED |
9 |
0.0001 |
| 225 |
ABNORMAL LOSS OF WEIGHT |
1 |
0.0001 |
| 226 |
ONYCHOCLASIS |
1 |
0.0001 |
| 227 |
PAPULE |
1 |
0.0001 |
| 228 |
METASTASIS |
1 |
0.0001 |
| 229 |
FAECES SOFT |
1 |
0.0001 |
| 230 |
UNDERDOSE |
10 |
0.0001 |
| 231 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
3 |
0.0001 |
| 232 |
GENERAL SYMPTOM |
1 |
0.0001 |
| 233 |
COLITIS |
5 |
0.0001 |
| 234 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 235 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
0.0001 |
| 236 |
INJECTION SITE RASH |
4 |
0.0001 |
| 237 |
FOOD ALLERGY |
1 |
0.0001 |
| 238 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 239 |
INCORRECT DOSE ADMINISTERED |
29 |
0.0001 |
| 240 |
FURUNCLE |
1 |
0.0001 |
| 241 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 242 |
RENAL CYST |
1 |
0.0001 |
| 243 |
ASPHYXIA |
1 |
0.0001 |
| 244 |
ABNORMAL FAECES |
1 |
0.0001 |
| 245 |
FLUSHING |
12 |
0.0001 |
| 246 |
ERECTILE DYSFUNCTION |
3 |
0.0001 |
| 247 |
MUSCULOSKELETAL DISCOMFORT |
2 |
0.0001 |
| 248 |
PANCREATITIS |
6 |
0.0001 |
| 249 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 250 |
INJECTION SITE BRUISING |
9 |
0.0001 |
| 251 |
INJECTION SITE HAEMORRHAGE |
9 |
0.0001 |
| 252 |
LUPUS-LIKE SYNDROME |
1 |
0.0001 |
| 253 |
HIDRADENITIS |
1 |
0.0001 |
| 254 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 255 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 256 |
UPPER RESPIRATORY TRACT INFECTION |
5 |
0.0001 |
| 257 |
FLANK PAIN |
1 |
0.0001 |
| 258 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 259 |
LEUKAEMIA |
1 |
0.0001 |
| 260 |
FRACTURE |
2 |
0.0001 |
| 261 |
INJECTION SITE SWELLING |
8 |
0.0001 |
| 262 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 263 |
COELIAC DISEASE |
1 |
0.0001 |
| 264 |
HEPATOMEGALY |
1 |
0.0001 |
| 265 |
FEEDING DISORDER |
2 |
0.0001 |
| 266 |
FEELING HOT |
6 |
0.0001 |
| 267 |
INJECTION SITE ERYTHEMA |
12 |
0.0001 |
| 268 |
DRUG-INDUCED LIVER INJURY |
3 |
0.0001 |
| 269 |
ABDOMINAL PAIN |
22 |
0.0001 |
| 270 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 271 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 272 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 273 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 274 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 275 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 276 |
HEPATOTOXICITY |
2 |
0.0001 |
| 277 |
INJECTION SITE PRURITUS |
6 |
0.0001 |
| 278 |
RASH PAPULAR |
2 |
0.0001 |
| 279 |
THERAPY NON-RESPONDER |
4 |
0.0001 |
| 280 |
TRANSIENT ISCHAEMIC ATTACK |
3 |
0.0001 |
| 281 |
HEPATIC ENZYME INCREASED |
6 |
0.0001 |
| 282 |
MYOCARDITIS |
1 |
0.0001 |
| 283 |
INJECTION SITE REACTION |
6 |
0.0001 |
| 284 |
CARDIAC FAILURE |
7 |
0.0001 |
| 285 |
VASCULITIS |
1 |
0.0001 |
| 286 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 287 |
PULMONARY EMBOLISM |
8 |
0.0001 |
| 288 |
CHOLECYSTITIS |
1 |
0.0001 |
| 289 |
WRIST FRACTURE |
1 |
0.0001 |
| 290 |
DISCOMFORT |
5 |
0.0001 |
| 291 |
INJECTION SITE URTICARIA |
2 |
0.0001 |
| 292 |
NASOPHARYNGITIS |
15 |
0.0001 |
| 293 |
PNEUMONIA ASPIRATION |
2 |
0.0001 |
| 294 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 295 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 296 |
HYPOPHAGIA |
2 |
0.0001 |
| 297 |
CHEST DISCOMFORT |
8 |
0.0001 |
| 298 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 299 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 300 |
DEEP VEIN THROMBOSIS |
5 |
0.0001 |
| 301 |
TOOTH INFECTION |
1 |
0.0001 |
| 302 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 303 |
ASPARTATE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 304 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 305 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 306 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 307 |
BLOOD BILIRUBIN INCREASED |
2 |
0.0001 |
| 308 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 309 |
RASH PRURITIC |
4 |
0.0001 |
| 310 |
UVEITIS |
1 |
0.0001 |
| 311 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 312 |
ARTHRALGIA |
30 |
0.0001 |
| 313 |
MASS |
1 |
0.0001 |
| 314 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 315 |
SUBDURAL HAEMATOMA |
1 |
0.0001 |
| 316 |
HYPERSOMNIA |
2 |
0.0001 |
| 317 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 318 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
| 319 |
ACUTE MYOCARDIAL INFARCTION |
2 |
0.0001 |
| 320 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
3 |
0.0001 |
| 321 |
LYMPHOMA |
1 |
0.0001 |
| 322 |
EXPOSURE DURING PREGNANCY |
4 |
0.0001 |
| 323 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 324 |
ARRHYTHMIA |
3 |
0.0001 |
| 325 |
HEAD INJURY |
2 |
0.0001 |
| 326 |
ABSCESS |
1 |
0.0001 |
| 327 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 328 |
NIGHT SWEATS |
2 |
0.0001 |
| 329 |
RASH |
27 |
0.0001 |
| 330 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 331 |
DRUG INEFFECTIVE |
81 |
0.0001 |
| 332 |
OSTEONECROSIS |
2 |
0.0001 |
| 333 |
INFUSION RELATED REACTION |
4 |
0.0001 |
| 334 |
THERAPEUTIC RESPONSE SHORTENED |
2 |
0.0001 |
| 335 |
PERICARDITIS |
1 |
0.0001 |
| 336 |
FACE OEDEMA |
1 |
0.0001 |
| 337 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 338 |
MYALGIA |
10 |
0.0001 |
| 339 |
THERAPY CESSATION |
3 |
0.0001 |
| 340 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 341 |
INFLAMMATION |
3 |
0.0001 |
| 342 |
DIARRHOEA |
37 |
0.0001 |
| 343 |
DRUG ERUPTION |
1 |
0.0001 |
| 344 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
4 |
0.0001 |
| 345 |
THIRST |
1 |
0.0001 |
| 346 |
GASTROINTESTINAL DISORDER |
5 |
0.0001 |
| 347 |
GOUT |
1 |
0.0001 |
| 348 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 349 |
INFECTION |
8 |
0.0001 |
| 350 |
PYREXIA |
19 |
0.0001 |
| 351 |
BRONCHITIS |
4 |
0.0001 |
| 352 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 353 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 354 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 355 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 356 |
ERUCTATION |
1 |
0.0001 |
| 357 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 358 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 359 |
SYNCOPE |
5 |
0.0000 |
| 360 |
SPINAL FRACTURE |
1 |
0.0000 |
| 361 |
FOETAL EXPOSURE DURING PREGNANCY |
4 |
0.0000 |
| 362 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 363 |
ALANINE AMINOTRANSFERASE INCREASED |
3 |
0.0000 |
| 364 |
HAEMOGLOBIN DECREASED |
5 |
0.0000 |
| 365 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 366 |
RIB FRACTURE |
1 |
0.0000 |
| 367 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 368 |
ILLNESS |
5 |
0.0000 |
| 369 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 370 |
URTICARIA |
8 |
0.0000 |
| 371 |
DERMATITIS |
1 |
0.0000 |
| 372 |
MOUTH ULCERATION |
1 |
0.0000 |
| 373 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 374 |
MENTAL DISORDER |
2 |
0.0000 |
| 375 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 376 |
CONSTIPATION |
10 |
0.0000 |
| 377 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 378 |
LIVER DISORDER |
2 |
0.0000 |
| 379 |
DEHYDRATION |
6 |
0.0000 |
| 380 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 381 |
NEOPLASM MALIGNANT |
3 |
0.0000 |
| 382 |
INFLUENZA |
5 |
0.0000 |
| 383 |
THROAT IRRITATION |
2 |
0.0000 |
| 384 |
PARAESTHESIA |
7 |
0.0000 |
| 385 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 386 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
8 |
0.0000 |
| 387 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 388 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 389 |
HEADACHE |
27 |
0.0000 |
| 390 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 391 |
PRURITUS |
16 |
0.0000 |
| 392 |
LOCALISED INFECTION |
1 |
0.0000 |
| 393 |
PRESYNCOPE |
1 |
0.0000 |
| 394 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 395 |
COVID-19 |
7 |
0.0000 |
| 396 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 397 |
GASTRIC CANCER |
1 |
0.0000 |
| 398 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 399 |
HAEMATOMA |
1 |
0.0000 |
| 400 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 401 |
HAEMORRHAGE |
4 |
0.0000 |
| 402 |
DEAFNESS |
1 |
0.0000 |
| 403 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 404 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 405 |
GASTRITIS |
1 |
0.0000 |
| 406 |
DEPRESSED MOOD |
2 |
0.0000 |
| 407 |
CHEST PAIN |
7 |
0.0000 |
| 408 |
HYPERSENSITIVITY |
7 |
0.0000 |
| 409 |
THROMBOSIS |
3 |
0.0000 |
| 410 |
PALLOR |
1 |
0.0000 |
| 411 |
PNEUMONITIS |
1 |
0.0000 |
| 412 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 413 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 414 |
DIVERTICULITIS |
1 |
0.0000 |
| 415 |
FEELING COLD |
1 |
0.0000 |
| 416 |
ALOPECIA |
7 |
0.0000 |
| 417 |
BLISTER |
2 |
0.0000 |
| 418 |
EYE PAIN |
2 |
0.0000 |
| 419 |
ASTHMA |
4 |
0.0000 |
| 420 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 421 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 422 |
LETHARGY |
2 |
0.0000 |
| 423 |
BONE PAIN |
2 |
0.0000 |
| 424 |
DIZZINESS |
17 |
0.0000 |
| 425 |
ERYTHEMA |
7 |
0.0000 |
| 426 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 427 |
OESOPHAGEAL CARCINOMA |
1 |
0.0000 |
| 428 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 429 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 430 |
HEPATIC FAILURE |
1 |
0.0000 |
| 431 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 432 |
CONDITION AGGRAVATED |
10 |
0.0000 |
| 433 |
EPILEPSY |
1 |
0.0000 |
| 434 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 435 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 436 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 437 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 438 |
RHINORRHOEA |
2 |
0.0000 |
| 439 |
IMPAIRED HEALING |
1 |
0.0000 |
| 440 |
HEART RATE INCREASED |
3 |
0.0000 |
| 441 |
DECREASED APPETITE |
7 |
0.0000 |
| 442 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 443 |
LIP SWELLING |
1 |
0.0000 |
| 444 |
EYE PRURITUS |
1 |
0.0000 |
| 445 |
WEIGHT DECREASED |
8 |
0.0000 |
| 446 |
RASH MACULAR |
1 |
0.0000 |
| 447 |
HEART RATE DECREASED |
1 |
0.0000 |
| 448 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 449 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 450 |
PNEUMONIA |
9 |
0.0000 |
| 451 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 452 |
PANIC ATTACK |
1 |
0.0000 |
| 453 |
OFF LABEL USE |
24 |
0.0000 |
| 454 |
SEPSIS |
3 |
0.0000 |
| 455 |
HYPOAESTHESIA |
4 |
0.0000 |
| 456 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 457 |
SEIZURE |
3 |
0.0000 |
| 458 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 459 |
PALPITATIONS |
3 |
0.0000 |
| 460 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 461 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 462 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 463 |
FALL |
8 |
0.0000 |
| 464 |
POLLAKIURIA |
1 |
0.0000 |
| 465 |
HYPOACUSIS |
1 |
0.0000 |
| 466 |
PSORIASIS |
3 |
0.0000 |
| 467 |
DYSPNOEA |
13 |
0.0000 |
| 468 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 469 |
ANGIOEDEMA |
1 |
0.0000 |
| 470 |
SKIN IRRITATION |
1 |
0.0000 |
| 471 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 472 |
NAUSEA |
17 |
0.0000 |
| 473 |
RENAL DISORDER |
1 |
0.0000 |
| 474 |
BREAST CANCER |
2 |
0.0000 |
| 475 |
COUGH |
6 |
0.0000 |
| 476 |
CARDIAC DISORDER |
2 |
0.0000 |
| 477 |
MIGRAINE |
2 |
0.0000 |
| 478 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 479 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 480 |
FATIGUE |
16 |
0.0000 |
| 481 |
DRY EYE |
1 |
0.0000 |
| 482 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 483 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
| 484 |
SINUSITIS |
2 |
0.0000 |
| 485 |
ABDOMINAL PAIN UPPER |
4 |
0.0000 |
| 486 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 487 |
VOMITING |
9 |
0.0000 |
| 488 |
ECZEMA |
1 |
0.0000 |
| 489 |
SPEECH DISORDER |
1 |
0.0000 |
| 490 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 491 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 492 |
PAIN |
11 |
0.0000 |
| 493 |
NECK PAIN |
1 |
0.0000 |
| 494 |
FLATULENCE |
1 |
0.0000 |
| 495 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 496 |
HERPES ZOSTER |
1 |
0.0000 |
| 497 |
BACK PAIN |
4 |
0.0000 |
| 498 |
SURGERY |
1 |
0.0000 |
| 499 |
NASAL CONGESTION |
1 |
0.0000 |
| 500 |
WHEEZING |
1 |
0.0000 |
| 501 |
CATARACT |
1 |
0.0000 |
| 502 |
MALAISE |
7 |
0.0000 |
| 503 |
ASTHENIA |
6 |
0.0000 |
| 504 |
ANAEMIA |
3 |
0.0000 |
| 505 |
HYPERHIDROSIS |
2 |
0.0000 |
| 506 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 507 |
DRY SKIN |
2 |
0.0000 |
| 508 |
SOMNOLENCE |
3 |
0.0000 |
| 509 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 510 |
DYSGEUSIA |
1 |
0.0000 |
| 511 |
ACNE |
1 |
0.0000 |
| 512 |
ARTHRITIS |
1 |
0.0000 |
| 513 |
FEELING ABNORMAL |
3 |
0.0000 |
| 514 |
PROSTATE CANCER |
1 |
0.0000 |
| 515 |
CARDIAC ARREST |
1 |
0.0000 |
| 516 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 517 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 518 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 519 |
BALANCE DISORDER |
1 |
0.0000 |
| 520 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 521 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 522 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 523 |
MUSCLE SPASMS |
2 |
0.0000 |
| 524 |
SWELLING |
1 |
0.0000 |
| 525 |
ANXIETY |
3 |
0.0000 |
| 526 |
DYSPHAGIA |
1 |
0.0000 |
| 527 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 528 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 529 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 530 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 531 |
DYSPEPSIA |
1 |
0.0000 |
| 532 |
HYPOTENSION |
2 |
0.0000 |
| 533 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 534 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 535 |
WEIGHT INCREASED |
2 |
0.0000 |
| 536 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 537 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 538 |
JOINT SWELLING |
1 |
0.0000 |
| 539 |
INSOMNIA |
2 |
0.0000 |
| 540 |
NEUTROPENIA |
1 |
0.0000 |
| 541 |
VISION BLURRED |
1 |
0.0000 |
| 542 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 543 |
DEATH |
6 |
0.0000 |
| 544 |
HOSPITALISATION |
1 |
0.0000 |
| 545 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 546 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 547 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 548 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 549 |
HYPERTENSION |
1 |
0.0000 |
| 550 |
OVERDOSE |
1 |
0.0000 |
| 551 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |